What AI says about Insilico Medicine
Insilico Medicine provides platforms for target discovery, biology modeling, and lead discovery to support drug development and scientific research.
AI calls itend-to-end,generative AI,AI-driven,novel,AI-native,proprietary
Since Jul 5Updated Nov 14, 2026Based on 11,389 AI answers
Reviewed by Dimitry Apollonsky
2%
of AI answers about Insilico Medicine and its rivals · since Jul 5
Based on 11,389 AI answers
- ChatGPT2%
- Google AI Mode2%
How often AI mentions Insilico Medicine
of AI answers about Insilico Medicine and its rivals
- · ChatGPT switched to GPT-6 Luna
Markets where AI mentions Insilico Medicine
Topics where AI mentions Insilico Medicine
- Most mentionedMentioned in
- Which AI platform is best for identifying novel drug targets for a biotech?on this questionRecursion shares the lead for mentions with 1 more88%
Excerpts where Insilico Medicine appeared in the AI's answer
Google AI ModeSep 29, 2026, Google AI Mode Insilico Medicine (Pharma.AI): One of the most clinically validated end-to-end platforms.
Google AI ModeSep 17, 2026, Google AI Mode Insilico Medicine (Insilico Pharma.AI): Best for an end-to-end generative approach.
- What's the best AI tool to design small molecules with better predicted potency?on this questionInsilico Medicine shares the lead for mentions with 2 more63%
Excerpts where Insilico Medicine appeared in the AI's answer
Google AI ModeSep 26, 2026, Google AI Mode Insilico Medicine Chemistry42 : An industry-leading generative AI platform
ChatGPTSep 22, 2026, ChatGPT Insilico Medicine Chemistry42 — particularly good for generative chemistry and hit/lead optimization.
- Which AI-native platforms help small biotech teams compete with large pharma research groups?on this questionRecursion shares the lead for mentions with 1 more73%
Excerpts where Insilico Medicine appeared in the AI's answer
Google AI ModeSep 28, 2026, Google AI Mode Insilico Medicine (Pharma.AI / Chemistry42): Insilico provides an end-to-end generative AI engine
Google AI ModeSep 12, 2026, Google AI Mode Insilico Medicine deploys its end-to-end generative AI platform, Pharma.AI
- What AI tools help biotech teams prioritize compounds before expensive wet lab work?on this questionSchrödinger shares the lead for mentions with 1 more61%
Excerpts where Insilico Medicine appeared in the AI's answer
Google AI ModeSep 24, 2026, Google AI Mode Insilico Medicine (Pharma.AI) : Utilizes generative adversarial networks (GANs) and reinforcement learning through its Pharma.AI platform to design novel molecules and prioritize lead series with optimized pharmacokinetic properties.
Google AI ModeSep 20, 2026, Google AI Mode Chemistry42 (Insilico Medicine): An enterprise generative chemistry platform that integrates AI-powered design with multi-parameter optimization.
- Our lab wants AI to propose molecules, design experiments, and learn from results. What discovery engines should we evaluate?on this questionInsilico Medicine shares the lead for mentions with 3 more41%
Excerpts where Insilico Medicine appeared in the AI's answer
Google AI ModeSep 28, 2026, Google AI Mode Insilico Medicine Chemistry42: Part of the broader Pharma.AI ecosystem, this platform combines generative AI with physics-based methods
Google AI ModeAug 31, 2026, Google AI Mode Insilico Medicine (Pharma/Biotech): Their platform, Insilico Medicine , covers target identification through generative chemistry and clinical-stage design.
- We want to model toxicity and safety earlier in drug development. Which AI platforms are credible?on this questionSchrödinger shares the lead for mentions with 2 more44%
Excerpts where Insilico Medicine appeared in the AI's answer
ChatGPTSep 26, 2026, ChatGPT Insilico Medicine — broad Pharma.AI platform spanning discovery through development
Google AI ModeSep 10, 2026, Google AI Mode Insilico Medicine employs its proprietary Pharma.AI suite, which includes modules for target discovery and generative chemistry
Insilico Medicine in AI answers
What's the best AI tool to design small molecules with better predicted potency?
Sites AI cites
- Your site25%
- Main | Insilico Medicine (opens in a new tab) · 10%
- Chemistry42 (opens in a new tab) · 3%
- Chemistry42 | Insilico Medicine (opens in a new tab) · 3%
- ACS Central Science | Researchers from Insilico Medicine and Lilly publish foundational vision for fully autonomous “Prompt-to-Drug” pharmaceutical R&D (opens in a new tab) · 2%
- Target Identification and Assessment in the Era of AI (opens in a new tab) · 1%
- A Phase 2 Readout Generates Excitement for the Potential of AI-Driven Drug Discovery (opens in a new tab) · 1%
- Biology42: Generative Biologics (opens in a new tab) · 1%
- Insilico Medicine (opens in a new tab) · 1%
- Insilico Medicine Advances AI-Driven Target Discovery with Validated TargetPro–TargetBench Framework (opens in a new tab) · 1%
- Pharma.AI Summer Update Preview: Drive the future of pharmaceutical intelligence (opens in a new tab) · 1%
- 7%
- Checking your browser - reCAPTCHA (opens in a new tab) · 3%
- Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine - PMC (opens in a new tab) · 1%
- AI-Driven Drug Discovery: A Comprehensive Review - PMC (opens in a new tab) · 1%
- Application of artificial intelligence large language models in drug target discovery (opens in a new tab) · 1%
- Progress of AI-Driven Drug–Target Interaction Prediction and ... (opens in a new tab) · 1%
- From Prompt to Drug: Toward Pharmaceutical Superintelligence (opens in a new tab) · 1%
- 4%
- Chemistry42: An AI-based platform for de novo molecular design (opens in a new tab) · 3%
- AlphaFold Accelerates Artificial Intelligence Powered Drug Discovery: Efficient Discovery of a Novel Cyclin-dependent Kinase 20 (CDK20) Small Molecule Inhibitor (opens in a new tab) · 1%
- An Auditable Agent Platform For Automated Molecular Optimisation (opens in a new tab) · 1%
- 4%
- Leading artificial intelligence–driven drug discovery platforms (opens in a new tab) · 2%
- Leading artificial intelligence–driven drug discovery platforms (opens in a new tab) · 1%
- Generative AI for drug discovery and protein design (opens in a new tab) · 1%
- A Review of the Applications, Benefits, and Challenges ... (opens in a new tab) · 1%
- 4%
- AI-First Drug Design: Accelerating the Discovery of New ... (opens in a new tab) · 2%
- AI-Native Discovery Engines (opens in a new tab) · 1%
- A Short Overview of AI Trends in Drug Discovery - 2026+ (opens in a new tab) · 1%
- Generative AI in Drug Discovery and Pharma, with Insilico Medicine ... (opens in a new tab) · 1%
- Molecule Optimization with Generative AI (opens in a new tab) · 1%
- 3%
- AI Cuts Drug Discovery Time in Half. Here’s the Patent Trail Proving It. (opens in a new tab) · 2%
- AI-developed Drugs Bring IP and Regulatory Risks: Navigating the New Frontier of Pharmaceutical Innovation (opens in a new tab) · 1%
- AI-Driven Drug Discovery: Transforming the Landscape of ... (opens in a new tab) · 1%
- The AI Revolution in Drug Repurposing: A Comprehensive Pipeline Analysis from Target Identification to Clinical and Commercial Validation - DrugPatentWatch – Transform Data into Market Domination (opens in a new tab) · 1%

